
Jean F. Voltaire
Examiner (ID: 18083, Phone: (571)272-3953 , Office: P/2466 )
| Most Active Art Unit | 2466 |
| Art Unit(s) | 2466, 2417 |
| Total Applications | 487 |
| Issued Applications | 381 |
| Pending Applications | 55 |
| Abandoned Applications | 68 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5010561
[patent_doc_number] => 20070281040
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-06
[patent_title] => 'COMBINATION THERAPY OF HEDGEHOG INHIBITORS, RADIATION AND CHEMOTHERAPEUTIC AGENTS'
[patent_app_type] => utility
[patent_app_number] => 11/576310
[patent_app_country] => US
[patent_app_date] => 2005-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11534
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20070281040.pdf
[firstpage_image] =>[orig_patent_app_number] => 11576310
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/576310 | COMBINATION THERAPY OF HEDGEHOG INHIBITORS, RADIATION AND CHEMOTHERAPEUTIC AGENTS | Sep 29, 2005 | Abandoned |
Array
(
[id] => 4803616
[patent_doc_number] => 20080015205
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-01-17
[patent_title] => 'Cancer Combination Therapy Comprising Azd2171 and Imatinib'
[patent_app_type] => utility
[patent_app_number] => 11/663912
[patent_app_country] => US
[patent_app_date] => 2005-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7930
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20080015205.pdf
[firstpage_image] =>[orig_patent_app_number] => 11663912
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/663912 | Cancer Combination Therapy Comprising Azd2171 and Imatinib | Sep 22, 2005 | Abandoned |
Array
(
[id] => 5801664
[patent_doc_number] => 20060035981
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-16
[patent_title] => 'Inhibition of anaerobic glucose metabolism and corresponding composition as a natural non-toxic approach to cancer treatment'
[patent_app_type] => utility
[patent_app_number] => 11/233279
[patent_app_country] => US
[patent_app_date] => 2005-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 12768
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0035/20060035981.pdf
[firstpage_image] =>[orig_patent_app_number] => 11233279
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/233279 | Inhibition of anaerobic glucose metabolism and corresponding composition as a natural non-toxic approach to cancer treatment | Sep 19, 2005 | Abandoned |
Array
(
[id] => 5415976
[patent_doc_number] => 20090041863
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-12
[patent_title] => 'Use of GSK3 inhibitors in combination with radiation therapies'
[patent_app_type] => utility
[patent_app_number] => 11/663314
[patent_app_country] => US
[patent_app_date] => 2005-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 24044
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0041/20090041863.pdf
[firstpage_image] =>[orig_patent_app_number] => 11663314
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/663314 | Use of GSK3 inhibitors in combination with radiation therapies | Sep 18, 2005 | Issued |
Array
(
[id] => 5638110
[patent_doc_number] => 20060069084
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-30
[patent_title] => 'Methods of inhibiting kinases'
[patent_app_type] => utility
[patent_app_number] => 11/223633
[patent_app_country] => US
[patent_app_date] => 2005-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9014
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0069/20060069084.pdf
[firstpage_image] =>[orig_patent_app_number] => 11223633
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/223633 | Methods of inhibiting kinases | Sep 8, 2005 | Abandoned |
Array
(
[id] => 5131599
[patent_doc_number] => 20070207996
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-09-06
[patent_title] => 'Novel Compositions And Methods Of Treatment'
[patent_app_type] => utility
[patent_app_number] => 11/660460
[patent_app_country] => US
[patent_app_date] => 2005-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22049
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0207/20070207996.pdf
[firstpage_image] =>[orig_patent_app_number] => 11660460
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/660460 | Novel Compositions And Methods Of Treatment | Aug 29, 2005 | Abandoned |
Array
(
[id] => 5814976
[patent_doc_number] => 20060084660
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-20
[patent_title] => 'Calcium channel blockers comprising two benzhydril moieties'
[patent_app_type] => utility
[patent_app_number] => 11/214218
[patent_app_country] => US
[patent_app_date] => 2005-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 9084
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0084/20060084660.pdf
[firstpage_image] =>[orig_patent_app_number] => 11214218
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/214218 | Calcium channel blockers comprising two benzhydril moieties | Aug 28, 2005 | Abandoned |
Array
(
[id] => 6978631
[patent_doc_number] => 20050288349
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-29
[patent_title] => 'Cancer treatments and pharmaceutical compositions therefor'
[patent_app_type] => utility
[patent_app_number] => 11/212300
[patent_app_country] => US
[patent_app_date] => 2005-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3843
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0288/20050288349.pdf
[firstpage_image] =>[orig_patent_app_number] => 11212300
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/212300 | Cancer treatments and pharmaceutical compositions therefor | Aug 25, 2005 | Abandoned |
Array
(
[id] => 4999379
[patent_doc_number] => 20070042013
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-02-22
[patent_title] => 'Long acting injectable formulations'
[patent_app_type] => utility
[patent_app_number] => 11/207980
[patent_app_country] => US
[patent_app_date] => 2005-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 20515
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0042/20070042013.pdf
[firstpage_image] =>[orig_patent_app_number] => 11207980
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/207980 | Long acting injectable formulations | Aug 18, 2005 | Issued |
Array
(
[id] => 5010549
[patent_doc_number] => 20070281028
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-06
[patent_title] => 'Drug Delivery of a Cox Inhibitor from Embolic Agents'
[patent_app_type] => utility
[patent_app_number] => 11/573172
[patent_app_country] => US
[patent_app_date] => 2005-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 12678
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20070281028.pdf
[firstpage_image] =>[orig_patent_app_number] => 11573172
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/573172 | Drug Delivery of a Cox Inhibitor from Embolic Agents | Aug 3, 2005 | Abandoned |
Array
(
[id] => 4814044
[patent_doc_number] => 20080194675
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-14
[patent_title] => 'Mixture of Catechins or Rather Polyphenols Extracted from Chinese Green Tea or Other Vegetables for the Prevention of Prostate Cancer and for the Treatment of Prostate Hypertrophy (Bph)'
[patent_app_type] => utility
[patent_app_number] => 11/658614
[patent_app_country] => US
[patent_app_date] => 2005-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3117
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0194/20080194675.pdf
[firstpage_image] =>[orig_patent_app_number] => 11658614
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/658614 | Mixture of catechins or rather polyphenols extracted from chinese green tea or other vegetables for the prevention of prostate cancer and for the treatment of prostate hypertrophy (BPH) | Jul 20, 2005 | Issued |
Array
(
[id] => 7550776
[patent_doc_number] => 08063109
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-11-22
[patent_title] => 'Formulations for parenteral administration of (e)-2, 6-dialkoxystyryl 4-substituted benzylsulfones'
[patent_app_type] => utility
[patent_app_number] => 11/658054
[patent_app_country] => US
[patent_app_date] => 2005-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 16847
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/063/08063109.pdf
[firstpage_image] =>[orig_patent_app_number] => 11658054
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/658054 | Formulations for parenteral administration of (e)-2, 6-dialkoxystyryl 4-substituted benzylsulfones | Jul 14, 2005 | Issued |
Array
(
[id] => 4760024
[patent_doc_number] => 20080312250
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-18
[patent_title] => 'Combination Comprising a Bcrp Inhibitor and 4- (4-Methylpiperazin-1-Ylmethyl)-N-[4-Methyl-3- (4-Pyridin-3-Yl) Pyrimidin-2-Ylamino) Phenyl] -Benzamide'
[patent_app_type] => utility
[patent_app_number] => 11/570888
[patent_app_country] => US
[patent_app_date] => 2005-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4457
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0312/20080312250.pdf
[firstpage_image] =>[orig_patent_app_number] => 11570888
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/570888 | Combination Comprising a Bcrp Inhibitor and 4- (4-Methylpiperazin-1-Ylmethyl)-N-[4-Methyl-3- (4-Pyridin-3-Yl) Pyrimidin-2-Ylamino) Phenyl] -Benzamide | Jun 29, 2005 | Abandoned |
Array
(
[id] => 5771861
[patent_doc_number] => 20050267201
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-01
[patent_title] => 'Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same'
[patent_app_type] => utility
[patent_app_number] => 11/165896
[patent_app_country] => US
[patent_app_date] => 2005-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7993
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0267/20050267201.pdf
[firstpage_image] =>[orig_patent_app_number] => 11165896
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/165896 | Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same | Jun 23, 2005 | Abandoned |
Array
(
[id] => 5688986
[patent_doc_number] => 20060287301
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-21
[patent_title] => 'Novel formulations for phenothiazines, including fluphenazine and its derivatives'
[patent_app_type] => utility
[patent_app_number] => 11/156016
[patent_app_country] => US
[patent_app_date] => 2005-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11615
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20060287301.pdf
[firstpage_image] =>[orig_patent_app_number] => 11156016
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/156016 | Novel formulations for phenothiazines, including fluphenazine and its derivatives | Jun 16, 2005 | Abandoned |
Array
(
[id] => 7250862
[patent_doc_number] => 20050272773
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-08
[patent_title] => 'Use of R (+)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-flurophenyl)-ethyl]-4- piperidinemethanol for the treatment of sleep disorders and process for making pharmaceutical composition'
[patent_app_type] => utility
[patent_app_number] => 11/149521
[patent_app_country] => US
[patent_app_date] => 2005-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6466
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0272/20050272773.pdf
[firstpage_image] =>[orig_patent_app_number] => 11149521
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/149521 | Use of R (+)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-flurophenyl)-ethyl]-4- piperidinemethanol for the treatment of sleep disorders and process for making pharmaceutical composition | Jun 9, 2005 | Abandoned |
Array
(
[id] => 6604751
[patent_doc_number] => 20100063074
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-11
[patent_title] => 'Cancer Treatment Method'
[patent_app_type] => utility
[patent_app_number] => 11/569877
[patent_app_country] => US
[patent_app_date] => 2005-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11717
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0063/20100063074.pdf
[firstpage_image] =>[orig_patent_app_number] => 11569877
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/569877 | Cancer Treatment Method | May 31, 2005 | Abandoned |
Array
(
[id] => 211564
[patent_doc_number] => 07622470
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-11-24
[patent_title] => 'Treatment of T-cell lymphoma using 10-propargyl-10-deazaaminopterin'
[patent_app_type] => utility
[patent_app_number] => 11/141868
[patent_app_country] => US
[patent_app_date] => 2005-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 3532
[patent_no_of_claims] => 161
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/622/07622470.pdf
[firstpage_image] =>[orig_patent_app_number] => 11141868
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/141868 | Treatment of T-cell lymphoma using 10-propargyl-10-deazaaminopterin | May 30, 2005 | Issued |
Array
(
[id] => 7172292
[patent_doc_number] => 20050203060
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-15
[patent_title] => 'Methods of using thalidomide in combination with irinotecan'
[patent_app_type] => utility
[patent_app_number] => 11/126315
[patent_app_country] => US
[patent_app_date] => 2005-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7847
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20050203060.pdf
[firstpage_image] =>[orig_patent_app_number] => 11126315
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/126315 | Methods of using thalidomide in combination with irinotecan | May 10, 2005 | Issued |
Array
(
[id] => 112915
[patent_doc_number] => 07714026
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-05-11
[patent_title] => 'Pharmaceutical composition containing bakuchiol for treating woman osteoporosis'
[patent_app_type] => utility
[patent_app_number] => 11/126234
[patent_app_country] => US
[patent_app_date] => 2005-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3691
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/714/07714026.pdf
[firstpage_image] =>[orig_patent_app_number] => 11126234
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/126234 | Pharmaceutical composition containing bakuchiol for treating woman osteoporosis | May 10, 2005 | Issued |